| 000 | 01887 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250514035124.0 | ||
| 264 | 0 | _c20021206 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0929-1903 | ||
| 024 | 7 |
_a10.1038/sj.cgt.7700474 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKronenwett, Ralf | |
| 245 | 0 | 0 |
_aInhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides. _h[electronic resource] |
| 260 |
_bCancer gene therapy _cJul 2002 |
||
| 300 |
_a587-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 | _aCell Movement |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCollagen _xpharmacology |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntegrin alphaV _xgenetics |
| 650 | 0 | 4 |
_aLaminin _xpharmacology |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 | _aNucleic Acid Conformation |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aProteoglycans _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aUmbilical Veins _xcytology |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aGräf, Thorsten | |
| 700 | 1 | _aNedbal, Wolfgang | |
| 700 | 1 | _aWeber, Markus | |
| 700 | 1 | _aSteidl, Ulrich | |
| 700 | 1 | _aRohr, Ulrich-Peter | |
| 700 | 1 | _aMöhler, Thomas | |
| 700 | 1 | _aHaas, Rainer | |
| 773 | 0 |
_tCancer gene therapy _gvol. 9 _gno. 7 _gp. 587-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.cgt.7700474 _zAvailable from publisher's website |
| 999 |
_c11977070 _d11977070 |
||